| Literature DB >> 19549332 |
Denice C Bay1, Raymond J Turner.
Abstract
BACKGROUND: Members of the small multidrug resistance (SMR) protein family are integral membrane proteins characterized by four alpha-helical transmembrane strands that confer resistance to a broad range of antiseptics and lipophilic quaternary ammonium compounds (QAC) in bacteria. Due to their short length and broad substrate profile, SMR proteins are suggested to be the progenitors for larger alpha-helical transporters such as the major facilitator superfamily (MFS) and drug/metabolite transporter (DMT) superfamily. To explore their evolutionary association with larger multidrug transporters, an extensive bioinformatics analysis of SMR sequences (> 300 Bacteria taxa) was performed to expand upon previous evolutionary studies of the SMR protein family and its origins.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19549332 PMCID: PMC2716321 DOI: 10.1186/1471-2148-9-140
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
The distribution of SMR homologues into each of the three SMR protein family subclasses within Archaea and Bacteria.
| Halobacteria | 60 | 40 | 5 | 5 | 1 | ||||||
| Methanomicrobia | 40 | 60 | 5 | 5 | 1 | ||||||
| Actinobacteria | 6 | 43 | 48 | 4 | 54 | 28 | 2 | ||||
| Bacilli | 13 | 12 | 32 | 25 | 14 | 5 | 81 | 22 | 4 | ||
| Lactobacilli | 59 | 18 | 24 | 17 | 11 | 2 | |||||
| Bacteroidetes | 100 | 4 | 4 | 1 | |||||||
| Chlorobia | 7 | 53 | 40 | 15 | 9 | 2 | |||||
| Flavobacteria | 20 | 80 | 5 | 4 | 1 | ||||||
| Clostridia | 36 | 9 | 18 | 36 | 11 | 7 | 2 | ||||
| Cyanophyceae | 43 | 14 | 19 | 24 | 21 | 15 | 1 | ||||
| Deinococci | 63 | 25 | 13 | 6 | 3 | 2 | |||||
| Chlamydiales | 100 | 2 | 2 | 1 | |||||||
| Planctomycetacia | 50 | 50 | 3 | 3 | 1 | ||||||
| Chloroflexi | 43 | 14 | 43 | 8 | 7 | 1 | |||||
| α-proteobacteria | 48 | 45 | 4 | 2 | 1 | 100 | 63 | 2 | |||
| β-proteobacteria | 42 | 42 | 7 | 6 | 3 | 71 | 36 | 2 | |||
| γ-proteobacteria | 41 | 25 | 21 | 2 | 2 | 9 | 213 | 95 | 2 | ||
| δ-proteobacteria | 21 | 52 | 21 | 7 | 29 | 13 | 2 | ||||
| ε-proteobacteria | 6 | 40 | 54 | 35 | 11 | 3 | |||||
The number of SMR sequences for each kingdom and class are indicated by percentage.
a The number of SMR sequences for each kingdom and class are indicated as a percentage of the total number identified.
b yvaE genes are only paired with yvaD genes among Bacilli and Lactobacilli.
c PSMR pairs are indicated as follows corresponding to the indicated letter: ydgE and ydgF(A), ebrA and ebrB (B), ykkC and ykkD (C), yvdR and yvdS (D), and yvaE and yvaD (E)
d Qac refers to integron and plasmid derived seqeunces only.
Figure 1Phylogenetic tree of SMR protein family members selected from Archaea and Bacteria. The unrooted phylogenetic tree is based on a NJ analysis of 338 SMR protein sequences identified from various Archaeal and Bacterial species. Due to the large number of sequences and tight clustering of branches within this tree, genus and species names were omitted and taxa were described according to their bacterial class. NCBI accession numbers of all SMR protein sequences and their genus and species names are shown in Additional Files 1 and 3. Plasmid and integron encoded SMR proteins are underlined and E. coli (Eco-EmrE, Eco-SugE, and Eco-YdgE/Eco-YdgF) and B. subtilis (Bsu-EbrA/Bsu-EbrB, Bsu-YkkC/Bsu-YkkD, Bsu-YvdR/Bsu-YvdS, and Bsu-YvaE/Bsu-YvaD) SMR homologues are indicated at their respective branch. The Archaeal Archaeoglobus Afu-QacE sequence served as an outgroup for this analysis. Bootstrap values were calculated but not shown on this tree; refer to Additional File 1 for confidence values at the respective nodes. Branches are coloured corresponding to their SMR subclass designation, PSMR (blue), SUG (green), and SMP (black) and individual PSMR members are highlighted according the following colours; YvaE (yellow), YvaD (Grey), YkkC/YvdS (violet), YkkD/YvdR (pink), YdgE (red), YdgF (orange), EbrA/EbrB (light blue).
SMR subclass member diversity within putative metabolite operons and their association to common metabolite ORF based on genomic loci surveys of sequenced Archaeal and Bacterial chromosomes.
| Putative operons | 118 | lys | trp/aro | liv/ilv/pro | put/spe/bet | MFS/ABC/ecn/bleo | tetR/pbp | ugp/pls | fab/acc | ||
| Frequency in operon/total surveyed loci | 0.8% | 4.2% | 1.7%/0.8%/0.8% | 0.8%/1.7%/0.8% | 3.4%/2.5%/3.4%/0.8% | 5.1%/0.8% | 0.8%/2.5% | 1.7%/0.8% | |||
| Frequency of occurrence in each locus (10 gene radius) | 29.7% | 20.3% | 2.0% | 5.1% | 22.9% | 23.7% | 7.6% | 17.8% | |||
| Putative operons | 92 | lys | tyr | pro/his/met/cys | put/bet/dpp | ABC/bleo/hlx | tetR/pbp | glp | fab/ech | ||
| Frequency in operon/total surveyed loci | 1.1% | 1.1% | 1.1%/1.1%/1.1%/2.2% | 1.1%/3.3%/1.1% | 1.1%/1.1%/2.2% | 8.7%/1.1% | 3.3% | 1.1%/2.2% | |||
| Frequency of occurrence in each locus (10 gene radius) | 22.8% | 14.1% | 12.0% | 14.1% | 28.3% | 10.9% | 9.8% | 22.8% | |||
| Putative operons | 16 | --- | --- | pro | --- | MFS/ABC | tetR | --- | acp/fab | ||
| Frequency in operon/total surveyed loci | --- | --- | 12.5% | --- | 6.3%/18.8% | 1.1% | --- | 12.5%/6.3% | |||
| Frequency of occurrence in each locus (10 gene radius) | 25.0% | 18.8% | --- | 43.8% | 12.5% | 6.3% | 18.8% | ||||
| Putative operons | 7 | arg | --- | --- | --- | --- | tetR | --- | acp/fab | ||
| Frequency in operon/total surveyed loci | 14.3% | --- | --- | --- | --- | 14.3% | --- | 28.6% | |||
| Frequency of occurrence in each locus (10 gene radius) | 14.3% | --- | --- | --- | --- | 28.6% | --- | 42.9% | |||
| Putative operons | 22 | lysR | --- | --- | spe* | --- | --- | --- | --- | ||
| Frequency in operon/total surveyed loci | 4.5% | --- | --- | --- | --- | --- | --- | --- | |||
| Frequency of occurrence in each locus (10 gene radius) | 54.5% | --- | --- | 31.8% | 22.7% | --- | --- | 22.7% | |||
| Putative operons | 16 | --- | --- | --- | --- | --- | --- | --- | --- | ||
| Frequency in operon/total surveyed loci | --- | --- | --- | --- | --- | --- | --- | --- | |||
| Frequency of occurrence in each locus (10 gene radius) | 12.5% | 6.3% | --- | 6.3% | 31.3% | 43.8% | --- | 50.0% | |||
| Putative operons | 9 | --- | aro | liv | spe | MFS | --- | --- | --- | ||
| Frequency in operon/total surveyed loci | --- | 11.1% | 11.1% | 11.1% | 11.1% | --- | --- | --- | |||
| Frequency of occurrence in each locus (10 gene radius) | 22.2% | 55.6% | 11.1% | 11.1% | 33.3% | 33.3% | 11.1% | 44.4% | |||
| 3 | NA | NA | NA | NA | NA | NA | NA | NA | |||
| Putative operons | 118 | thi/nad | fol | --- | ubi | pur | ctp | tn/rve | vap/kill | --- | |
| Frequency in operon/total surveyed loci | 0.8/2.5% | 0.8% | --- | 1.7% | 4.2% | 0.8% | 2.5% | 2.5% | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | 7.6% | 1.7% | 2.5% | 11.9% | 22.0% | 3.4% | 21.2% | 9.3% | 5.9% | ||
| Putative operons | 92 | thi/nad | bio/fol | cob | --- | pur | --- | tn/rve | --- | Pro-phage DLP12 | |
| Frequency in operon/total surveyed loci | 1.1%/1.1% | 1.1%/1.1% | 2.2% | --- | 1.1% | --- | 3.3% | --- | 1.1% | ||
| Frequency of occurrence in each locus (10 gene radius) | 17.4% | 12.0% | 3.3% | 9.8% | 8.7% | 3.3% | 14.1% | 2.2% | 4.3% | ||
| Putative operons | 16 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |
| Frequency in operon/total surveyed loci | --- | --- | --- | --- | --- | --- | --- | --- | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | --- | 6.3% | --- | 25.0% | --- | --- | 12.5% | --- | --- | ||
| Putative operons | 7 | --- | --- | --- | ubi | pur | --- | --- | --- | --- | |
| Frequency in operon/total surveyed loci | --- | --- | --- | 28.6% | 14.3% | --- | --- | --- | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | --- | 14.3% | --- | 42.9% | 42.9% | 28.6% | 14.3% | --- | --- | ||
| Putative operons | 22 | --- | --- | --- | --- | --- | --- | tn/rve | tra/cop | --- | |
| Frequency in operon/total surveyed loci | --- | --- | --- | --- | --- | --- | 4.5% | 9.1% | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | 13.6% | 18.2% | --- | --- | 18.2% | 4.5% | 9.1% | 9.1% | 13.6% | ||
| Putative operons | 16 | nad* | fol | --- | --- | pur | --- | --- | --- | --- | |
| Frequency in operon/total surveyed loci | 12.5% | 6.3% | --- | --- | 6.3% | --- | --- | --- | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | 18.8% | 25.0% | 12.5% | 6.3% | 25.0% | --- | 25.0% | --- | 6.3% | ||
| Putative operons | 9 | rib | bio | --- | --- | pur | pyr | --- | cdt | --- | |
| Frequency in operon/total surveyed loci | 11.1% | 11.1% | --- | --- | 22.2% | 11.1% | --- | 11.1% | --- | ||
| Frequency of occurrence in each locus (10 gene radius) | 22.2% | 11.1% | 11.1% | --- | 33.3% | 11.1% | 11.1% | 11.1% | --- | ||
| 3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
* Indicates these SMR members have experimentally demonstrated transport involvement in the metabolite transport.
** Calculated value listed in table includes both isogenic gene occurances and gene pairs.
Abreviations of genes listed in table: ABC ABC-type antimicrobial peptide transport system; aro aromatic amino acid biosynthesis; bet transport and biosynthesis/degradation of glycine betaines; bleo bleomycin resistance genes; bio involved in biotin (vitamin B7) metabolism; cdt plasmid encoded cytotoxin genes; cob involved in cobalamin vitamin B6 metabolism; dpp ABC-type dipeptide/oligopeptide/nickel transport system; fol involved in folate metabolism; glp utilization of glycerol and sn-glycerol 3-phosphate (sn-G3P); hlx hemolysin genes involved in host virulence; lysR lysine transcriptional regulator; liv/ile branched amino acid biosynthesis (val, ile, leu); met/pro/his/cys amino acid biosynthetic genes; MFS multidrug efflux major facillitator superfamily genes; nad involved in nicotine and nicotinamide metabolism; nag GlcNAc uptake and metabolism; nai (niacin) vitamin B3 metabolism; pbp penicillin binding proteins/cell wall biosynthesis proteins; pls involved in sn-glycerol-3-phosphate phsopholipid biosynthesis; put transport and biosynthesis/degradation of putrescine; pts phosphoenolpyruvate-dependent phosphotransferase system; pur involved in purine nucleotide biosynthesis; pyd (pyridoxine) vitamin B12 metabolism pyr involved in pyrimidine nucleotide biosynthesis; rib involved in riboflavin metabolism; spe transport and biosynthesis/degradation of spermidine; tetR tetracyclin resistance transcriptional regulator; thi (thiamin) vitamin B1 metabolism; tn/rve transposons and integron maturases; trp/tyr biosynthesis of tryptophan/tyrosine; ubi involved in ubiquinone (coenzyme Q10) biosynthesis; ugp uptake of sn-glycerol-3-phosphate and glycerophosphoryl diesters; vap/kill host plasmid virulence and toxin genes.
Summary of synonymous to non-synonymous nucleotide substitution patterns within SMR family subclasses SMP and SUG.
| 57.27 | 83.94 | 79.63 | 220.37 | 0.72 | 0.38 | 1.68 | 0.55 | |||
| Hsa- | Tfu- | 39.12 | 88.88 | 85.17 | 214.83 | 0.46 | 0.41 | 0.71 | 0.6 | 1.18 |
| Ser- | 43.12 | 90.88 | 85.5 | 214.5 | 0.5 | 0.42 | 0.84 | 0.62 | 1.34 | |
| Cli- | 55 | 86 | 82.33 | 217.67 | 0.67 | 0.4 | 1.66 | 0.56 | 2.96 | |
| Fjo- | 71.88 | 90.12 | 77.67 | 222.33 | 0.93 | 0.41 | NA | 0.58 | NA | |
| Ssp- | 50.25 | 88.75 | 84.83 | 215.17 | 0.59 | 0.41 | 1.17 | 0.6 | 1.95 | |
| Cau- | 56 | 85 | 82.83 | 217.17 | 0.68 | 0.39 | 1.74 | 0.55 | 3.14 | |
| Bja- | 44.88 | 86.12 | 83.5 | 216.5 | 0.54 | 0.4 | 0.95 | 0.57 | 1.67 | |
| Bme- | 55.38 | 70.62 | 83.67 | 216.33 | 0.66 | 0.33 | 1.61 | 0.43 | 3.75 | |
| Bxe- | 49.88 | 77.12 | 85.5 | 214.5 | 0.58 | 0.36 | 1.13 | 0.49 | 2.30 | |
| Pae- | 46.88 | 77.12 | 85.33 | 214.67 | 0.55 | 0.36 | 0.99 | 0.49 | 2.02 | |
| Eco- | 66.5 | 96.5 | 79.33 | 220.67 | 0.84 | 0.44 | NA | 0.66 | NA | |
| Gsu- | 49.88 | 78.12 | 84.5 | 215.5 | 0.59 | 0.36 | 1.16 | 0.5 | 2.34 | |
| I- | 65.62 | 77.38 | 81.17 | 218.83 | 0.81 | 0.35 | NA | 0.48 | NA | |
| PI- | 64.12 | 85.88 | 81.67 | 218.33 | 0.79 | 0.39 | NA | 0.56 | NA | |
| P- | 47.75 | 79.25 | 80.83 | 219.17 | 0.59 | 0.36 | 1.16 | 0.49 | 2.35 | |
| P- | 61 | 89 | 80.67 | 219.33 | 0.76 | 0.41 | NA | 0.58 | NA | |
| P- | 71.25 | 102.75 | 76.5 | 223.5 | 0.93 | 0.46 | NA | 0.71 | NA | |
| P- | 72.88 | 92.12 | 78 | 222 | 0.93 | 0.41 | NA | 0.6 | NA | |
| Eco- | Tfu- | 70.75 | 98.25 | 79.5 | 220.5 | 0.89 | 0.45 | NA | 0.68 | NA |
| Ser- | 67.62 | 105.38 | 79.83 | 220.17 | 0.85 | 0.48 | NA | 0.76 | NA | |
| Cli- | 57.5 | 79.5 | 76.67 | 223.33 | 0.75 | 0.36 | NA | 0.48 | NA | |
| Fjo- | 52.88 | 86.12 | 72 | 228 | 0.73 | 0.38 | 2.9 | 0.53 | 5.53 | |
| Ssp- | 61 | 104 | 79.17 | 220.83 | 0.77 | 0.47 | NA | 0.74 | NA | |
| Cau- | 55.25 | 85.75 | 77.17 | 222.83 | 0.72 | 0.38 | 2.32 | 0.54 | 4.30 | |
| Bja- | 63.62 | 82.38 | 77.83 | 222.17 | 0.82 | 0.37 | NA | 0.51 | NA | |
| Bme- | 59.12 | 75.88 | 78 | 222 | 0.76 | 0.34 | NA | 0.46 | NA | |
| Bxe- | 63 | 74 | 79.83 | 220.17 | 0.79 | 0.34 | NA | 0.45 | NA | |
| Pae- | 64.38 | 85.62 | 79.67 | 220.33 | 0.81 | 0.39 | NA | 0.55 | NA | |
| Gsu- | 62.25 | 69.75 | 78.83 | 221.17 | 0.79 | 0.32 | NA | 0.41 | NA | |
| I- | 47.5 | 84.5 | 75.5 | 224.5 | 0.63 | 0.38 | 1.37 | 0.52 | 2.62 | |
| PI- | 47.5 | 88.5 | 76 | 224 | 0.62 | 0.4 | 1.34 | 0.56 | 2.39 | |
| P- | 63.75 | 73.25 | 75.17 | 224.83 | 0.85 | 0.33 | NA | 0.43 | NA | |
| P- | 60.12 | 83.88 | 75 | 225 | 0.8 | 0.37 | NA | 0.52 | NA | |
| P- | 52.62 | 97.38 | 70.83 | 229.17 | 0.74 | 0.42 | 3.5 | 0.63 | 5.58 | |
| P- | 53.38 | 88.62 | 72.33 | 227.67 | 0.74 | 0.39 | 3.1 | 0.55 | 5.64 | |
| 55.11 | 91.77 | 78.26 | 221.74 | 0.71 | 0.41 | 1.83 | 0.63 | |||
| Hla- | Mba- | 60.5 | 73.5 | 75.83 | 224.17 | 0.8 | 0.33 | NA | 0.43 | NA |
| Tfu- | 45.25 | 75.75 | 80.83 | 219.17 | 0.56 | 0.35 | 1.03 | 0.46 | 2.22 | |
| Ser- | 39.5 | 87.5 | 80.83 | 219.17 | 0.49 | 0.4 | 0.79 | 0.57 | 1.39 | |
| Cli- | 61.25 | 76.75 | 78.83 | 221.17 | 0.78 | 0.35 | NA | 0.47 | NA | |
| Fjo-SugE | 64.75 | 82.25 | 75.17 | 224.83 | 0.86 | 0.37 | NA | 0.5 | NA | |
| Gvo- | 50.38 | 66.62 | 80.83 | 219.17 | 0.62 | 0.3 | 1.33 | 0.39 | 3.42 | |
| Bja- | 47.25 | 74.75 | 80 | 220 | 0.59 | 0.34 | 1.16 | 0.45 | 2.57 | |
| Bme- | 55.38 | 79.62 | 78.5 | 221.5 | 0.71 | 0.36 | 2.12 | 0.49 | 4.33 | |
| Bxe- | 50.25 | 72.75 | 80 | 220 | 0.63 | 0.33 | 1.36 | 0.44 | 3.13 | |
| Pae- | 49.5 | 82.5 | 80.83 | 219.17 | 0.61 | 0.38 | 1.27 | 0.52 | 2.43 | |
| Pae- | 47.12 | 57.88 | 82 | 218 | 0.57 | 0.27 | 1.09 | 0.33 | 3.33 | |
| Eco- | 62 | 66 | 79.83 | 220.17 | 0.78 | 0.3 | NA | 0.38 | NA | |
| Gsu- | 51.88 | 67.12 | 81.17 | 218.83 | 0.64 | 0.31 | 1.43 | 0.39 | 3.63 | |
| I- | 62.38 | 109.62 | 78.5 | 221.5 | 0.79 | 0.49 | NA | 0.81 | NA | |
| PI- | 60.12 | 116.88 | 79 | 221 | 0.76 | 0.53 | NA | 0.92 | NA | |
| P- | 48.88 | 115.12 | 78.17 | 221.83 | 0.63 | 0.52 | 1.35 | 0.88 | 1.52 | |
| P- | 51.75 | 116.25 | 78 | 222 | 0.66 | 0.52 | 1.62 | 0.9 | 1.80 | |
| P- | 70.12 | 110.88 | 73.83 | 226.17 | 0.95 | 0.49 | NA | 0.8 | NA | |
| P- | 68.75 | 111.25 | 75.33 | 224.67 | 0.91 | 0.5 | NA | 0.81 | NA | |
| P-Cfr- | 62.62 | 68.38 | 80.17 | 219.83 | 0.78 | 0.31 | NA | 0.4 | NA | |
| I- | 56 | 89 | 79.83 | 220.17 | 0.7 | 0.4 | 2.05 | 0.58 | 3.54 | |
| Eco- | Mba- | 61.62 | 83.38 | 76 | 224 | 0.81 | 0.37 | NA | 0.51 | NA |
| Tfu- | 60.38 | 76.62 | 81 | 219 | 0.75 | 0.35 | 3.82 | 0.47 | 8.10 | |
| Ser- | 53.12 | 78.88 | 81 | 219 | 0.66 | 0.36 | 1.56 | 0.49 | 3.17 | |
| Cli- | 57.25 | 65.75 | 79 | 221 | 0.72 | 0.3 | 2.54 | 0.38 | 6.71 | |
| Fjo- | 57.25 | 91.75 | 75.33 | 224.67 | 0.76 | 0.41 | NA | 0.59 | NA | |
| Gvo- | 60.75 | 59.25 | 81 | 219 | 0.75 | 0.27 | NA | 0.34 | NA | |
| Bsp- | 55 | 68 | 80.17 | 219.83 | 0.69 | 0.31 | 1.85 | 0.4 | 4.63 | |
| Bme- | 59.12 | 60.88 | 78.67 | 221.33 | 0.75 | 0.28 | NA | 0.34 | NA | |
| Bxe- | 56.62 | 56.38 | 80.17 | 219.83 | 0.71 | 0.26 | 2.13 | 0.31 | 6.80 | |
| Pae- | 57.75 | 69.25 | 81 | 219 | 0.71 | 0.32 | 2.26 | 0.41 | 5.49 | |
| Pae- | 59.88 | 46.12 | 82.17 | 217.83 | 0.73 | 0.21 | 2.67 | 0.25 | 10.74 | |
| Gsu- | 62.75 | 52.25 | 81.33 | 218.67 | 0.77 | 0.24 | NA | 0.29 | NA | |
| I- | 57 | 102 | 78.67 | 221.33 | 0.72 | 0.46 | 2.54 | 0.71 | 3.55 | |
| PI- | 54.5 | 109.5 | 79.17 | 220.83 | 0.69 | 0.5 | 1.87 | 0.81 | 2.31 | |
| P- | 56.38 | 113.62 | 78.33 | 221.67 | 0.72 | 0.51 | 2.41 | 0.86 | 2.79 | |
| P- | 60.5 | 99.5 | 78.17 | 221.83 | 0.77 | 0.45 | NA | 0.68 | NA | |
| P- | 54.5 | 120.5 | 74 | 226 | 0.74 | 0.53 | 3.01 | 0.93 | 3.24 | |
| P- | 53.25 | 118.75 | 75.5 | 224.5 | 0.71 | 0.53 | 2.12 | 0.92 | 2.31 | |
| P-Cfr- | 47.38 | 26.62 | 80.33 | 219.67 | 0.59 | 0.12 | 1.16 | 0.13 | 8.75 | |
| I- | 59 | 98 | 80 | 220 | 0.74 | 0.45 | 3.07 | 0.68 | 4.54 | |
List of abreviations: Sd is the number of observed synonymous substitutions; Nd is the number of observed non-synonymous substitutions; S is the number of potential synonymous substitutions; N is the number of potential non-synonymous substitutions; pS is the proportion of observed synonymous substitutions; pN is the proportion of observed non-synonymous substitutions; dS is the Jukes-Cantor correction for multiple hits of pS; dN is the Jukes-Cantor correction for multiple hits of pN.
Species are listed according to a three letter species abbreviation followed by the SMR subclass name: Bja Bradyrhizobium japonicum; Bme Brucella melitensis; Bsp Bradyrhizobium sp. ORS278; Bxe Burkholderia xenovorans; Cau Chloroflexus aurantiacus; Cfr Citrobacter freundii; Cli Chlorobium limicola; Fjo Flavobacterium johnsoniae; Gsu Geobacter sulfurreducens; Gvo Gloeobacter violaceus; Hla Halorubrum lacusprofundi; Hsa Halobacterium salinarum; Mba Methanosarcina barkeri; Pae Pseudomonas aeruginosa; Ser Saccharopolyspora erythraea; Ssp Synechococcus sp. RS9917; Tfu Thermobifida fusca; P plasmid encoded; I integron encoded; PI plasmid/integron encoded; NA data not available.
Figure 2Summary of SUG and PSMR (YkkC/YvdS and YkkD/YvdR) amino acid residue consensus and mean synonymous substitutions (Mean Sd) observed at each position within their overall sequence alignments. Data is shown for SMR members in each panel as follows: A) SUG subclass, B) PSMR subclass members YkkC/YvdS, and C) PSMR subclass members YkkD/YvdR. The amino acid(s) that occurred with the highest frequency at each position within the alignment is indicated on the x-axis below each bar and dashes indicate positions lacking amino acid alignment. Each bar represents the degree of conservation of the listed amino acid(s) below based on its percentage (Consensus %; grey bars) according to the left- hand y-axis. Mean Sd values shown on the right- hand y-axis were calculated from Syn-SCAN pairwise comparisons of Sd values for 20 SMR homologues from each SMR subclass alignment. Mean Sd values, represented as black bars, indicate the level of observed synonymous nucleotide substitutions within the codon for each consensus amino acid listed below.
Figure 3Summary of SMP and PSMR (YdgF and YdgE) amino acid residue consensus and mean synonymous substitutions (Mean Sd) observed at each position within their overall sequence alignments. Data is shown for SMR members in each panel as follows: A) SMP subclass including integron encoded Qac members, B) PSMR subclass member YdgE, C) PSMR subclass member YdgF. Figure legend details are identical to those described for Figure 2; refer to this figure for details.
Figure 4Summary of PSMR (EbrA/EbrB, YvaE and YvaD) amino acid residue consensus and mean synonymous substitutions (Mean Sd) observed at each position within their overall sequence alignments. Data is shown for SMR members in each panel as follows:A) PSMR subclass members, EbrA and EbrB, B) PSMR subclass member YvaE, and C) PSMR subclass member YvaD. Figure legend details are identical to those described for Figure 2; refer to this figure for details.
Figure 5TM domain alignments of SMR proteins to drug and metabolite transporters from BAT and DMT protein families. Protein alignments were performed using ClustalW and manual editing using GeneDoc (v 2.5.010 [64]). Artificial fusions proteins of all SMR proteins from each subclass were performed (data not shown) and selected alignments for the fused protein pairs Eco-YdgF to Eco-YdgE and Eco-EmrE to Eco-SugE are shown in panel B. TM domains for SMR proteins are highlighted in red whereas all other predicted TM domains are highlighted in blue. M residues are boxed in red in each alignment in both panels to indicate the starting residue for SMR fusion sequences. Conserved residues at a given position within TM domains are indicated by the amino acid letter below the sequence and moderate to high amino acid similarity is indicated by a single or two dots respectively at each position. Panel A indicates the alignment of Eco-SugE and Eco-EmrE sequences to predicted TM domains of BAT family proteins from Archaeal Aquifex aeolicus (AAC07598; 143 a.a.) and Bacterial Neisseria meningitidis (AAF42175; 143 a.a.). Panel B shows alignments of Eco-EmrE to Eco-SugE and Eco-YdgF to Eco-YdgF fusions is aligned with the DMT superfamily members E. coli RarD (ZP_03000057; 286 a.a.) and Salmonella enterica PagO (ZP_03162845; 304 a.a).
Figure 6TM domain alignments of SMR proteins with MFS members. Artificial fusions proteins of all SMR proteins from each subclass were performed (data not shown) and selected alignments for the fused protein pairs Bsu-EbrA to Bsu-EbrB, and Eco-EmrE to Eco-SugE are shown with MFS transporters from Pseudomonas aeruginosa (NP_253969; 389 a.a) and from N. meningitidis (NP_273492; 400 a.a). For further details describing this figure refer to the description provided in Figure 5.
Figure 7A diagram cartoon showing SMR protein TM strand evolution to generate members of the BAT, and DMT protein families. SMR TM domains conversion is based on TM alignments to larger drug transporters shown in Figure 5. TM strands from a putative SMR protein are shown as filled rectangles and numbered according to their position within the protein. Unnumbered vertically lined rectangles indicate TM strands gained within BAT and DME proteins. N- and C-termini are no longer shown in the figure to account for topological orientations changes that may contribute to this process. An alternative SMR/PSMR protein fusion model is also shown based on SMR fusion alignments which may also contribute to a 10 TM stranded DMT protein. For this model, fusion of two PSMR sequences and the subsequent gain of TM domains show the formation of 10 TM domain DMT transporters.